Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Clinical Therapeutics

Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime

W. Cliff Rutter, Jessica N. Cox, Craig A. Martin, Donna R. Burgess, David S. Burgess
W. Cliff Rutter
aUniversity of Kentucky College of Pharmacy, Lexington, Kentucky, USA
bUniversity of Kentucky HealthCare, Lexington, Kentucky, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica N. Cox
bUniversity of Kentucky HealthCare, Lexington, Kentucky, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig A. Martin
aUniversity of Kentucky College of Pharmacy, Lexington, Kentucky, USA
bUniversity of Kentucky HealthCare, Lexington, Kentucky, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donna R. Burgess
aUniversity of Kentucky College of Pharmacy, Lexington, Kentucky, USA
bUniversity of Kentucky HealthCare, Lexington, Kentucky, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David S. Burgess
aUniversity of Kentucky College of Pharmacy, Lexington, Kentucky, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.02089-16
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1128/AAC.02089-16
PubMed 
27895019

Published By 
American Society for Microbiology Journals
History 
  • Received September 30, 2016
  • Returned for modification October 19, 2016
  • Accepted November 21, 2016
  • Published online January 24, 2017.

Copyright & Usage 
Copyright © 2017 American Society for Microbiology. All Rights Reserved .

Article Versions

  • Accepted Manuscript version (November 28, 2016).
  • You are viewing the most recent version of this article.

Author Information

  1. W. Cliff Ruttera,b,
  2. Jessica N. Coxb,
  3. Craig A. Martina,b,
  4. Donna R. Burgessa,b and
  5. David S. Burgessa
  1. aUniversity of Kentucky College of Pharmacy, Lexington, Kentucky, USA
  2. bUniversity of Kentucky HealthCare, Lexington, Kentucky, USA
  • Address correspondence to David S. Burgess, david.burgess{at}uky.edu.
  • Citation Rutter WC, Cox JN, Martin CA, Burgess DR, Burgess DS. 2017. Nephrotoxicity during vancomycin therapy in combination with piperacillin-tazobactam or cefepime. Antimicrob Agents Chemother 61:e02089-16. https://doi.org/10.1128/AAC.02089-16 .

Article usage

Article usage: November 2016 to February 2021

Rendering graph...
AbstractFullPdf
Nov 2016234012
Dec 2016695072
Jan 201783121135
Feb 201767240116
Mar 20174231092
Apr 20172471052
May 2017236650
Jun 20172132697
Jul 201716032117
Aug 201715744151
Sep 20178573107
Oct 201792179137
Nov 201782213114
Dec 20175521889
Jan 201875343112
Feb 20187632785
Mar 20188830993
Apr 20189732281
May 20186626154
Jun 20184825754
Jul 20186433081
Aug 2018127453108
Sep 20181243393
Oct 201814509120
Nov 201815416111
Dec 2018431655
Jan 20197417126
Feb 20192638987
Mar 2019123367110
Apr 201913036497
May 2019100339125
Jun 201959366100
Jul 201916137978
Aug 201928519560
Sep 201927517266
Oct 201928015465
Nov 201920413151
Dec 201910810541
Jan 20202613050
Feb 20201512946
Mar 20201311345
Apr 2020167632
May 2020127130
Jun 20201810845
Jul 2020209144
Aug 2020149230
Sep 20201911153
Oct 20201212752
Nov 2020279344
Dec 20201210326
Jan 2021147735
Feb 2021136228
PreviousNext
Back to top
Download PDF
Citation Tools
Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime
W. Cliff Rutter, Jessica N. Cox, Craig A. Martin, Donna R. Burgess, David S. Burgess
Antimicrobial Agents and Chemotherapy Jan 2017, 61 (2) e02089-16; DOI: 10.1128/AAC.02089-16

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime
W. Cliff Rutter, Jessica N. Cox, Craig A. Martin, Donna R. Burgess, David S. Burgess
Antimicrobial Agents and Chemotherapy Jan 2017, 61 (2) e02089-16; DOI: 10.1128/AAC.02089-16
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

cephalosporins
Penicillanic Acid
vancomycin
nephrotoxicity
piperacillin-tazobactam
adverse drug effects
beta-lactams
cefepime
vancomycin

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596